The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?

Detalles Bibliográficos
Autor principal: Han, Ji Whan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2017
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378023/
https://www.ncbi.nlm.nih.gov/pubmed/28382072
http://dx.doi.org/10.4070/kcj.2017.0011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378023/
https://www.ncbi.nlm.nih.gov/pubmed/28382072
http://dx.doi.org/10.4070/kcj.2017.0011

Ejemplares similares